Tolerability of agomelatine;Verträglichkeitsprofil von agomelatin

Psychopharmakotherapie

Volumn 16, Issue 2, 2009, Pages 11-14

  Laux, Gerd ^a,b  

^a Akademisches Lehrkrankenhaus der Ludwig Maximilians Universitat Munchen ^*

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Agomelatine; Antidepressants; Side effects; Tolerability

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG MONITORING; DRUG TOLERABILITY; ECG ABNORMALITY; FATIGUE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFECTION; LIVER FUNCTION TEST; MAJOR DEPRESSION; NAUSEA; RHINOPHARYNGITIS; SEXUAL DYSFUNCTION; SOMNOLENCE; VERTIGO; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 64849096662     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Eser D, Baghai TC, Möller HJ. Psychophar- makotherapie 2008;15:51-6.
2. Fachinf'ormation zu Valdoxan (Vorlage BfArM).
3. Johnson D. Intern Med 1996;11:14-7.
4. Kennedy SH. Eur Neuropsychopharmacol 2006;16:S619-24.
5. Kennedy SH, Emsley R. Eur Neuropsychopharmacol 2006;16:93-100.
6. Laux G, Dietmaier O. Praktische Psychophar- makotherapie. 5. Auflage. Munchen: Elsevier Urban & Fischer, 2006.
7. Lemoine P, Guilleminault C. Alvarez E. J Clin Psychiatry 2007;68:1723-32.
8. Loo H, Hale A, D'Haenen H. Int Clin Psychopharmacol 2002;17:239-47.
9. Montgomery SA. Kennedy SH, Burrows GD. Lejoyeux M, et al. Int Clin Psychopharmacol 2004;19:271-80.
10. Montgomery SA. Eur Neuropsychopharmacol 2006;16(Suppl 5):S633-8.
11. OliéP, Kasper S. Int J Neuropsychopharmacol 2007;10:661 -73.
12. Rote Liste 2009. Arzneimittelverzeichnis fur Deutschland. Frankfurt/Main: Rote Liste" Service GmbH, 2009.
13. Rouillon F. Int Clin Psychopharmacol 2006;2l(Suppl t):S31-5
14. Rothschild AJ. J Clin Psychiatry 2000;61(Suppl 11):28-36.